Reprogramming Strategies of Promoting Optic Nerve Regeneration and Vision Restoration
Reprogramming Strategies of Promoting Optic Nerve Regeneration and Vision Restoration
批准号:
9322464
负责人:
ZHIGANG HE
金额:
$44.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2021-07-31
关键词:
AdultAnatomyAxonBiological AssayBlindnessBrainCandidate Disease GeneCellsCircadian RhythmsDevelopmentExhibitsEyeFRAP1 geneGenetic TranscriptionGrowthIGF1 geneLabelLightMethodsModelingMolecularMusNatural regenerationOptic NerveOptic Nerve InjuriesPTEN genePathway interactionsPhotosensitivityPilot ProjectsProteinsRecovery of FunctionResearchRetinal Ganglion CellsSOX11 geneSOX4 geneStem Cell ResearchTechnologyVisionVisual Pathwaysaxon regenerationbasebehavior testcircadian pacemakercombinatorialexperimental studyfunctional outcomesfunctional restorationimprovedinduced pluripotent stem cellinjuredinsightmelanopsinnerve supplyneuronal survivalnovelnovel strategiesoptic nerve regenerationosteopontinoverexpressionpreventregenerativerestorationretinal progenitor cellsuprachiasmatic nucleustranscription factorvisual information
中文摘要
项目摘要
视神经轴突的损伤阻止了视觉信息从眼睛到大脑的传递,
导致视力丧失因此,我们的研究一直集中在开发方法,以促进有效的
视神经轴突再生和重建功能性视觉通路。最近的研究表明,
开发了几种刺激轴突再生的新策略,然而,这些方法中的每一种
仅在视网膜神经节细胞(RGC)的亚群中实现再生。因此,为了恢复视力,
是迫切需要的,以促进再生的多种类型的RGC。灵感来自于
为了获得iPS细胞,我们假设过表达某些转录,
成人RGC中的因子可以将它们重编程为类似于RGC的生长能力状态。为此我们
我已经筛选了一系列在分化过程中正常表达的转录因子
阶段的视网膜祖细胞,以检查哪一个(S),当在成人RGC中过表达时,可以使
使用眶内视神经损伤模型的显著轴突再生。有趣的是,我们发现,
转录因子Sox 11和Sox 4在较小程度上的表达导致了明显的视神经损伤。
再生初步分析显示,Sox 11的影响可能与Sox 11引发的影响不同。
PTEN缺失(参见方法)。此外,虽然PTEN缺失可选择性地促进细胞的再生,
α型RGCs,Sox11过表达促进黑视素表达的再生
光敏RGC(ipRGC)和其他未确定类型的RGC。这些初步发现表明,
通过恢复Sox 11表达促进视神经再生的新原理。在此,我们建议
探索Sox 11刺激RGC轴突再生的潜在机制及其潜力
应用,无论是本身或与其他组合,在实现功能恢复。
英文摘要
Project Summary
The damage of optic nerve axons prevents the relay of the visual information from the eye to the brain, leading
to the loss of vision. Therefore, our research has been focusing on developing methods to promote efficient
optic nerve axon regeneration and to re-build functional visual pathways. Recent studies have led to the
developments of several novel strategies that stimulate axon regeneration, however each of these methods
only achieved regeneration in subsets of retinal ganglion cells (RGCs). Thus, to restore vision, new strategies
are pressingly needed to promote regeneration of multiple types of RGCs. Inspired by the transcriptional
reprogramming technology for obtaining iPS cells, we hypothesized that over-expressing certain transcription
factors in adult RGCs could reprogram them into a young-RGC-like growth competent state. To this end, we
have performed a screen for a list of transcription factors that are normally expressed during the differentiation
stage of retinal progenitor cells, to examine which one(s), when overexpressed in adult RGCs, could enable
significant axon regeneration using an intraorbital optic nerve injury model. Interestingly, we found that forced
expression of the transcription factor Sox11, and to a less extent Sox4, resulted in marked optic nerve
regeneration. Preliminary analysis revealed that the effects of Sox11 are likely different from those triggered by
PTEN deletion (see Approach). Furthermore, while PTEN deletion promotes the regeneration selectively from
alpha type of RGCs, Sox11 overexpression promotes the regeneration of melanopsin-expressing intrinsically
photosensitive RGCs (ipRGCs) and other un-determined types of RGCs. These initial findings suggested a
novel rationale for promoting optic nerve regeneration by reinstitute Sox11 expression. Here, we propose to
explore the underlying mechanisms by which Sox11 stimulates RGC axon regeneration and its potential
application, either by itself or in combination with others, in achieving functional recovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10288673
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and spinal cord injury
-
批准号:9884826
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10599160
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10662464
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10018669
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10227071
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:9920148
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
-
批准号:10915759
-
项目类别:
-
资助金额:$5.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
-
批准号:10714331
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10094088
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:10402334
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)
-
批准号:10712799
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)
-
批准号:10847933
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:10610910
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:9895134
-
项目类别:
-
资助金额:$69.01万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10352309
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10468403
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10475030
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Cortical Signature and Modulation of Pain
-
批准号:10349650
-
项目类别:
-
资助金额:$57.36万
-
财政年份:2018
-
负责人:ZHIGANG HE
-
依托单位:
Cortical Signature and Modulation of Pain
-
批准号:10438580
-
项目类别:
-
资助金额:$79.54万
-
财政年份:2018
-
负责人:ZHIGANG HE
-
依托单位:
海外基金